https://www.selleckchem.com/pr....oducts/meclofenamate
0%), Medtronic CoreValve (9.1%) and Boston Lotus (12.3%; p less then 0.01). Pre-procedural pacing rates for the Boston Lotus valve have risen year-on-year from 5.8% (2013) to 8.6% (2014) to 12.3% (2015). The UK TAVI Registry demonstrates a pre-procedural permanent pacing bias amongst patients receiving transcatheter valves with higher post-procedure pacing rates. Pre-emptive permanent pacing is likely to be responsible for this difference.The synthesis and characterization of two half-sandwich complexes of Ru(II) and Ir(I
Мне нравится
Комментарий
Перепост
